impact of specific mutations on parp inhibition in prostate cancer
Published 5 years ago • 295 plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
0:31
which mutations benefit most from parp inhibitors in prostate cancer?
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
4:02
the emerging role of parp inhibitors in prostate cancer
-
3:56
parp inhibitors: activity in brca1 versus brca2 altered mcrpc
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
1:25
parp inhibitors: their applications and efficacy against prostate cancer
-
1:35
parp inhibitors for the treatment of metastic castration-resistant prostate cancer
-
2:09
current perspectives from clinical trials using parp inhibitors for prostate cancer
-
1:00
dr. morgan discusses the impact of parp inhibitors in prostate cancer
-
1:21
combining a parp and pd-l1 inhibitor to treat prostate cancer
-
2:30
parp inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
-
1:31
tackling disease progression whilst using parp inhibitors for prostate cancer
-
1:53
the evolving role of parp inhibitors in mcrpc
-
0:57
when is the optimal time to use parp inhibitors in prostate cancer patients?
-
1:32
dr. chang discusses the use of parp inhibitors in prostate cancer
-
16:22
role of parp inhibitors in prostate cancer
-
8:32
acting on actionable mutations: genetic testing and parp inhibitors for advanced prostate cancer
-
9:53
parp inhibitors for prostate cancer with moshe ornstein, md
-
1:43:31
webinar: parp-inhibitors and prostate cancer - gotta have a mutation??? 06/29/2023